Can we finally spot CTE before death? new study hopes to find out

NCT ID NCT06860828

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study is trying to find ways to diagnose chronic traumatic encephalopathy (CTE) in living people. Right now, CTE can only be confirmed after death. Researchers will study 350 former college and professional football players, using memory tests and other biomarkers. The goal is to better understand the condition and pave the way for future treatments.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

What this could lead to
If successful, this could lead to the first reliable way to diagnose CTE in living people, enabling future research on prevention and treatment.
What could go wrong
This is an observational study, not a treatment trial. It may not produce a diagnostic tool that works outside this specific group of former football players.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Alzheimer disease Brain Injuries, Traumatic Chronic Traumatic Encephalopathy dementia pugilistica traumatic brain injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • 1Florida ADRC, University of Florida

    Gainesville, Florida, 32610, United States

  • Banner Alzheimer's Institute (BAI) and Mayo Clinic Arizona

    Phoenix, Arizona, 85006, United States

  • Boston University Alzheimer Disease Research Center (ADRC)

    Boston, Massachusetts, 02118, United States

  • South Texas ADRC University of Texas Health Science Center at San Antonio

    San Antonio, Texas, 78229, United States

  • University of California, San Francisco (UCSF) Alzheimer Disease Research Center (ADRC)

    San Francisco, California, 94143, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.